Ken Yoshida

发表

Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study

H. Yamazaki, Satoaki Nakamura, D. Shimizu, 2020, Journal of clinical medicine.

High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report

Y. Uesugi, K. Nihei, M. Ohmichi, 2020, Journal of contemporary brachytherapy.

Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2011, Journal of radiation research.

High dose rate brachytherapy for oral cancer

Y. Yoshioka, H. Yamazaki, M. Koizumi, 2012, Journal of radiation research.

Is Radiation Therapy for Keloids Acceptable? The Risk of Radiation-Induced Carcinogenesis

R. Ogawa, T. Miyashita, Ken Yoshida, 2009, Plastic and reconstructive surgery.

Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy.

T. Tsujinaka, Y. Kurokawa, K. Fujitani, 2009, Anticancer research.

Artificial ascites for organs at risk sparing in intrapelvic brachytherapy: a case report of recurrent uterine cervical carcinoma adjacent to the bowel

Kana Takahashi, H. Igaki, J. Itami, 2018, BJR case reports.

Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.

Hiroyuki Okamoto, A. Wakita, Satoshi Nakamura, 2017, Brachytherapy.

Assessment of Influence of Smoking, Drinking, Leukoplakia and Dental Irritation on Local Control of Early Oral Tongue Carcinoma Treated with Brachytherapy: Age and Dental Factors are Potential Prognostic Factors

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2009, Tumori.

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors

T. Shiraishi, K. Okihara, Kei Yamada, 2021, Cancers.

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly

T. Shiraishi, K. Okihara, O. Ukimura, 2020, Clinical and Translational Radiation Oncology.

Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy.

H. Yamazaki, Satoaki Nakamura, D. Shimizu, 2018, Anticancer research.

Exceptionally high incidence of grade 2-3 late rectal toxicity in patients with prostate cancer receiving hypofractionated (2.2 Gy) soft tissue-matched image-guided intensity-modulated radiotherapy.

H. Yamazaki, Satoaki Nakamura, Norihiro Aibe, 2013, Anticancer research.

High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer

Kei Yamada, H. Yamazaki, J. Asai, 2020, Journal of radiation research.

Radiotherapy for laryngeal cancer—technical aspects and alternate fractionation

H. Yamazaki, T. Teshima, K. Ogawa, 2017, Journal of radiation research.

Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.

K. Himei, Y. Yoshioka, H. Yamazaki, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer

K. Himei, Y. Yoshioka, H. Yamazaki, 2016, Journal of radiation research.

Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study

T. Tsuzuki, H. Nishiyama, H. Ishikawa, 2021, Contemporary clinical trials communications.

Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary Glands

H. Yamazaki, H. Shiomi, R. Oh, 2022, Cureus.

Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies

Hiroyuki Okamoto, Satoshi Nakamura, Kana Takahashi, 2022, Journal of contemporary brachytherapy.

Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife

K. Himei, Y. Yoshioka, H. Yamazaki, 2015, Radiation Oncology.

Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2010, Radiation oncology.

Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy

Kei Yamada, H. Yamazaki, M. Koizumi, 2017, Oncology letters.

Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study.

K. Himei, Y. Yoshioka, H. Yamazaki, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preliminary result of accelerated partial breast irradiation after breast-conserving surgery

T. Nose, H. Yamazaki, N. Masuda, 2009, Breast cancer.

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10

T. Shiraishi, K. Okihara, Kei Yamada, 2022, Cancers.

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer

H. Yamazaki, Satoaki Nakamura, D. Shimizu, 2021, Cancers.

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy

H. Yamazaki, Satoaki Nakamura, D. Shimizu, 2021, Cancers.

Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy.

H. Yamazaki, T. Nakashima, Toshiaki Tanaka, 2014, Anticancer research.

Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.

H. Yamazaki, T. Nakashima, N. Hayabuchi, 2014, Anticancer research.

Quantitative evaluation of acute mucosal reaction to interstitial brachytherapy using color histograms.

M. Mitomo, T. Nose, O. Inaba, 2005, Brachytherapy.

Treatment results of radiotherapy with or without surgery for posterior pharyngeal wall cancer of oropharynx and hypopharynx: prognostic value of tumor extension.

E. Tanaka, H. Shiomi, T. Teshima, 2004, Radiation medicine.

Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report.

H. Yamazaki, M. Koizumi, T. Kagiya, 2013, Anticancer research.

Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy.

Kei Yamada, H. Yamazaki, M. Koizumi, 2013, Anticancer research.

Comparison of Re-irradiation Outcomes for Charged Particle Radiotherapy and Robotic Stereotactic Radiotherapy Using CyberKnife for Recurrent Head and Neck Cancers: A Multi-institutional Matched-cohort Analysis.

K. Himei, Y. Yoshioka, H. Yamazaki, 2016, Anticancer research.

Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2011, International journal of radiation oncology, biology, physics.

Frequency and predisposing factors for interfractional rectal displacement requiring repeated precaution in prostate cancer patients treated with image-guided intensity-modulated radiation therapy.

H. Yamazaki, Satoaki Nakamura, Hiroyasu Ikeno, 2014, Anticancer research.

Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers

Hiroyuki Okamoto, T. Ohno, K. Tsujino, 2022, Journal of radiation research.

Non-surgical multimodality treatment for locally advanced (T3-4) hypopharyngeal cancer: the impact of pre-treatment hemoglobin level.

H. Yamazaki, T. Nakashima, N. Hayabuchi, 2013, Anticancer research.

Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.

H. Yamazaki, Toshiaki Tanaka, H. Umeno, 2014, Anticancer research.

Gel spacer to protect carotid artery and reconstructed jejunum in image-guided interstitial brachytherapy for recurrent hypopharyngeal cancer: a technical report

Kana Takahashi, H. Igaki, J. Itami, 2021, Journal of contemporary brachytherapy.

Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2012, Journal of radiation research.

Brachytherapy for early oral tongue cancer: low dose rate to high dose rate.

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2003, Journal of radiation research.

Dose coverage comparison between “interstitial catheter-only” and “hybrid intracavitary-interstitial brachytherapy” for early stage squamous cell carcinoma of the buccal mucosa

Hiroyuki Okamoto, Kana Takahashi, H. Igaki, 2018, Journal of contemporary brachytherapy.

Assessment of radiation dermatitis using objective analysis for patients with breast cancer treated with breast-conserving therapy: influence of body weight

H. Yamazaki, Hiroyasu Ikeno, Norihiro Aibe, 2012, Japanese Journal of Radiology.

Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation.

H. Yamazaki, T. Nishimura, Norihiro Aibe, 2011, Journal of radiation research.

Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2016, Brachytherapy.

Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity

H. Yamazaki, E. Tanaka, Y. Ariji, 2022, Journal of contemporary brachytherapy.

Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx

Kana Takahashi, H. Igaki, J. Itami, 2020, BJR case reports.

Radiotherapy targeting cancer stem cells: current views and future perspectives.

Y. Yoshioka, H. Yamazaki, K. Ogawa, 2013, Anticancer research.

Interstitial Brachytherapy: Radical and Salvage

Ken Yoshida, 2018, Brachytherapy.

Clinico-pathological study on oral leukoplakia

Y. Kazaoka, Y. Takai, Ken Yoshida, 1990 .

High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2014, Journal of contemporary brachytherapy.

Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2007, Anticancer research.

Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy.

N. Kakimoto, Hironobu Nakamura, Y. Yoshioka, 2004, International journal of radiation oncology, biology, physics.

In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter.

T. Nose, M. Koizumi, D. Peiffert, 2005, International journal of radiation oncology, biology, physics.

Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study

H. Yamazaki, H. Shiomi, R. Oh, 2021, Cancers.

Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer

T. Kasamatsu, Y. Yoshioka, Hiroyuki Okamoto, 2022, Journal of gynecologic oncology.

A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan

H. Yamazaki, R. Oh, Satoaki Nakamura, 2020, Journal of radiation research.

A national surveillance study of the current status of reirradiation using brachytherapy in Japan.

H. Yamazaki, F. Isohashi, D. Shimizu, 2020, Brachytherapy.

Re-irradiation using interstitial brachytherapy increases vaginal mucosal reaction compared to initial brachytherapy in patients with gynecological cancer.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2013, Anticancer research.

Fractionation or tumor factors—what matters in carotid blowout syndrome?

H. Yamazaki, Satoaki Nakamura, Gen Suzuki, 2021, Strahlentherapie und Onkologie.

Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume.

K. Himei, Y. Yoshioka, H. Yamazaki, 2014, Anticancer research.

Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study

T. Nose, J. Itami, Kazutaka Nakashima, 2017, Japanese Journal of Radiology.

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: clinical results with a median follow-up of 26 months

T. Nose, J. Itami, Kazutaka Nakashima, 2016, Breast Cancer.

HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY FOR OROPHARYNX CANCER

T. Nose, M. Koizumi, Toshihiko Inoue, 2002 .

Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2017, Anticancer research.

Radiotherapy for locally advanced resectable T3–T4 laryngeal cancer—does laryngeal preservation strategy compromise survival?

H. Yamazaki, T. Teshima, K. Ogawa, 2017, Journal of radiation research.

Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color

Mariko Goto, Ken Yoshida, Kei Yamada, 2018, Scientific Reports.

Objective Assessment of Dermatitis Following Post-operative Radiotherapy in Patients with Breast Cancer Treated with Breast-conserving Treatment

H. Yamazaki, E. Tanaka, T. Nishimura, 2010, Strahlentherapie und Onkologie.

Longitudinal practical measurement of skin color and moisture during and after breast-conserving therapy: influence of neoadjuvant systemic therapy

H. Yamazaki, N. Masuda, K. Kuriyama, 2009, Japanese Journal of Radiology.

High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up.

Y. Yoshioka, H. Yamazaki, K. Ogawa, 2016, International journal of radiation oncology, biology, physics.

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

Kazuhiko Ogawa, Yasuo Yoshioka, Ken Yoshida, 2014, Journal of contemporary brachytherapy.

Monotherapeutic high-dose-rate brachytherapy for prostate cancer: a dose reduction trial.

Y. Yoshioka, H. Yamazaki, M. Koizumi, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer

Y. Yoshioka, H. Yamazaki, K. Ogawa, 2013, Journal of radiation research.

Influence of transitioning of planning techniques in high-dose-rate brachytherapy monotherapy for clinically localized prostate cancer from two- to three-dimensional planning.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2019, Brachytherapy.

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2018, Journal of clinical medicine.

Comparison of three moderate fractionated schedules employed in high-dose-rate brachytherapy monotherapy for clinically localized prostate cancer.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2018, Cancers.

Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.

Y. Yoshioka, H. Yamazaki, M. Koizumi, 2015, Anticancer research.

High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2014, Strahlentherapie und Onkologie.

Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancer.

Yasuo Yoshioka, Ken Yoshida, Koji Masui, 2014, Anticancer research.

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer

T. Shiraishi, Kei Yamada, H. Yamazaki, 2022, Scientific Reports.

Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer?

H. Yamazaki, Satoaki Nakamura, Koji Masui, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.

T. Shiraishi, K. Okihara, Kei Yamada, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer

T. Shiraishi, K. Okihara, Kei Yamada, 2021, Scientific Reports.

Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer

T. Shiraishi, K. Okihara, Kei Yamada, 2018, Scientific Reports.

Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients

Y. Harima, T. Ohno, Y. Kaneyasu, 2016, Journal of radiation research.

Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis

Y. Yoshioka, H. Yamazaki, M. Koizumi, 2014, Journal of radiation research.

A pilot study of wider use of accelerated partial Breast irradiation: Intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy

T. Nose, M. Koizumi, H. Koyama, 2006, Breast cancer.

Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer

Y. Uesugi, Y. Yoshioka, H. Yamazaki, 2013, Journal of radiation research.

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer

H. Yamazaki, Satoaki Nakamura, D. Shimizu, 2022, Scientific reports.

Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy

K. Himei, Y. Yoshioka, H. Yamazaki, 2017, Strahlentherapie und Onkologie.

A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with “intentional internal high-dose policy” high-dose-rate interstitial brachytherapy

Satoshi Nakamura, Kana Takahashi, H. Igaki, 2020, Medicine.

Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer.

Shigetoshi Yamada, Y. Uesugi, Y. Yoshioka, 2015, Brachytherapy.

A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience

Kana Takahashi, H. Igaki, J. Itami, 2019, BMC Cancer.

Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer.

Y. Uesugi, Y. Yoshioka, H. Yamazaki, 2015, Brachytherapy.

A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience

Kana Takahashi, H. Igaki, J. Itami, 2019, BMC Cancer.

High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.

N. Kakimoto, Y. Yoshioka, H. Yamazaki, 2006, Anticancer research.

Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer

Y. Uesugi, Y. Yoshioka, H. Yamazaki, 2015, Journal of gynecologic oncology.

Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2014, Anticancer research.

Assessment of planning target volume margin for a small number of vertebral metastatic lesions using image-guided intensity-modulated radiation therapy by helical tomotherapy.

H. Yamazaki, Satoaki Nakamura, F. Isohashi, 2013, Anticancer research.

Actuarial assessment and predisposing factor analysis for late vaginal stenosis after high-dose-rate brachytherapy in patients with previously untreated cervical cancer : role of vaginal pallor reaction

Y. Uesugi, Y. Yoshioka, H. Yamazaki, 2015 .

Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: speculation on the relation between pallor reaction and stenosis.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2013, Anticancer research.

A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.

Shigetoshi Yamada, H. Yamazaki, E. Tanaka, 2010, International journal of radiation oncology, biology, physics.

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance

T. Nose, J. Itami, Kazutaka Nakashima, 2015, Radiation oncology.

HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution

T. Nose, H. Yamazaki, E. Tanaka, 2023, Journal of contemporary brachytherapy.

Comparison of dose–volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer

H. Yamazaki, E. Tanaka, S. Tachiiri, 2012, Journal of radiation research.

TREATMENT RESULTS OF RADIOTHERAPY FOR EARLY TONGUE CANCER OF YOUNG AGE

H. Yamazaki, E. Tanaka, M. Koizumi, 1999 .

Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color

Kei Yamada, H. Yamazaki, M. Goto, 2018, Scientific Reports.

Case report of a dose-volume histogram analysis of rib fracture after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study

T. Nose, J. Itami, Kazutaka Nakashima, 2018, Journal of contemporary brachytherapy.

Objective and quantitative assessment in acute radiation-induced skin toxicity: Way to overcome the barriers?

H. Yamazaki, Gen Suzuki, Norihiro Aibe, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife®

K. Himei, Y. Yoshioka, H. Yamazaki, 2017, Molecular and clinical oncology.

Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study

H. Yamazaki, H. Shiomi, R. Oh, 2023, Scientific Reports.

Correlation Between Dosimetric Parameters and Acute Dermatitis of Post-operative Radiotherapy in Breast Cancer Patients

Kei Yamada, H. Yamazaki, D. Shimizu, 2018, In Vivo.

Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium.

S. Kariya, Y. Yoshioka, J. Itami, 2017, Brachytherapy.

Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2014, Anticancer research.

Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.

H. Yamazaki, E. Tanaka, Satoaki Nakamura, 2022, Brachytherapy.

Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?

T. Shiraishi, K. Okihara, Kei Yamada, 2019, Journal of clinical medicine.

Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group

Y. Yoshioka, A. Imai, K. Ogawa, 2012, Journal of radiation research.

Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience

Kana Takahashi, H. Igaki, J. Itami, 2019, Journal of radiation research.

Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?

Y. Uesugi, Y. Yoshioka, H. Yamazaki, 2016, Brachytherapy.

Is there clinical meaningful threshold in dose volume analysis between grade 0‐2 and 3‐4 radiation dermatitis?

H. Yamazaki, Gen Suzuki, Ken Yoshida, 2020, Head and Neck.

High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity.

Y. Yoshioka, T. Nose, H. Yamazaki, 2003, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma multiforme using simultaneous integrated boost technique.

H. Yamazaki, T. Kagiya, Satoaki Nakamura, 2013, Anticancer research.

New implant technique for separation of the seminal vesicle and rectal mucosa for high-dose-rate prostate brachytherapy.

H. Yamazaki, K. Kuriyama, Tohru Takahashi, 2007, Brachytherapy.

Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer.

Ken Yoshida, Hiroya Shiomi, Hideya Yamazaki, 2010, Brachytherapy.

In regard to Morganti et al.

H. Yamazaki, Satoaki Nakamura, Norihiro Aibe, 2015, International journal of radiation oncology, biology, physics.

Adjuvant Chemoradiation After Resection of Pancreatic Cancer In Regard to Morganti et al

H. Yamazaki, Norihiro Aibe, Ken Yoshida, 2015 .

Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife

K. Himei, Y. Yoshioka, H. Yamazaki, 2015, Radiation oncology.

PO-0937: HDR image-guided interstitial brachytherapy for postoperative local recurrent uterine cancer

Y. Uesugi, H. Yamazaki, E. Tanaka, 2017 .

Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate

Y. Shiki, Y. Yoshioka, E. Tanaka, 2015, Journal of radiation research.

Daily CT measurement of needle applicator displacement during multifractionated high-dose-rate interstitial brachytherapy for postoperative recurrent uterine cancer.

H. Yamazaki, E. Tanaka, Y. Koretsune, 2012, Journal of radiation research.

Daily computed tomography measurement of needle applicator displacement during high-dose-rate interstitial brachytherapy for previously untreated uterine cervical cancer.

Kazuya Honda, Ken Yoshida, Hideya Yamazaki, 2011, Brachytherapy.

The combination of volumetric arc radiation therapy and boost high-dose rate interstitial brachytherapy for T3N2c tongue cancer: a technical report.

Satoshi Nakamura, H. Igaki, S. Yoshimoto, 2022, Japanese journal of clinical oncology.

Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations.

H. Yamazaki, E. Tanaka, K. Honda, 2012, Journal of radiation research.

High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.

Y. Yoshioka, T. Nose, K. Yoshida, 2000, International journal of radiation oncology, biology, physics.

Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction

Kana Takahashi, H. Igaki, J. Itami, 2019, Journal of contemporary brachytherapy.

Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.

Y. Yoshioka, H. Yamazaki, M. Koizumi, 2015, Anticancer research.

Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy

Kei Yamada, H. Yamazaki, E. Tanaka, 2023, Journal of contemporary brachytherapy.